staurosporine has been researched along with 3-(1-deoxyribofuranosyl)benzamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chorváth, B; Duraj, J; Hunáková, L; Jayaram, HN; Kelley, MR; Novotný, L; Romanová, D; Sedlák, J; Szekeres, T | 1 |
| Dovinova, I; Hunakova, L; Jayaram, HN; Novotny, L; Rauko, P; Szekeres, T | 1 |
| Novotny, L; Rauko, P; Szekeres, T; Yalowitz, JA | 1 |
1 review(s) available for staurosporine and 3-(1-deoxyribofuranosyl)benzamide
| Article | Year |
|---|---|
Antitumor activity of benzamide riboside in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; DNA Replication; Female; Humans; IMP Dehydrogenase; In Vitro Techniques; Leukemia L1210; Nucleosides; Ovarian Neoplasms; Staurosporine; Survival Rate | 2002 |
2 other study(ies) available for staurosporine and 3-(1-deoxyribofuranosyl)benzamide
| Article | Year |
|---|---|
Staurosporine enhanced benzamide riboside-induced apoptosis in human multidrug-resistant promyelocytic leukemia cells (HL-60/VCR) in vitro.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA Fragmentation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; HL-60 Cells; Humans; IMP Dehydrogenase; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Nucleosides; Staurosporine | 1998 |
Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cisplatin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Leukemia L1210; Mice; Mice, Inbred DBA; Nucleosides; Staurosporine; Survival Rate | 2001 |